These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3075552)

  • 1. Intranasal LH-RH analogue treatment of precocious puberty.
    Koehler B; Koehler M; Osuch-Jaczewska R
    Exp Clin Endocrinol; 1988 Mar; 92(3):252-6. PubMed ID: 3075552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
    Lin TH; LePage ME; Henzl M; Kirkland JL
    J Pediatr; 1986 Dec; 109(6):954-8. PubMed ID: 2946840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subcutaneous and intranasal use of a LH-RH analog in the treatment of girls with central precocious puberty].
    Fideleff HL; Boquete HR; Azaretzky M; Damilano S; Cagide AL; Levalle O
    Medicina (B Aires); 1989; 49(6):567-72. PubMed ID: 2518644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and precocious puberty.
    Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
    Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precocious puberty and ovarian follicular cysts].
    Wemeau-Jacquemont C
    Pediatrie; 1988; 43(4):355-60. PubMed ID: 3047663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].
    Roger M; Chaussain JL; Bost M; Bozzola M; Colle M; Despert F; François R; Freycon F; Garandeau P; Malpuech G
    Rev Fr Gynecol Obstet; 1986 May; 81(5):297-305. PubMed ID: 2943013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
    Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].
    Partsch CJ; Hümmelink R; Lorenzen F; Sippell WG
    Monatsschr Kinderheilkd; 1989 May; 137(5):284-8. PubMed ID: 2525665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudo- and central precocious puberty due to adrenogenital syndrome].
    Pouw IS; Drop SL; Ladée-Levy JV; Slijper FM
    Tijdschr Kindergeneeskd; 1986 Jun; 54(3):77-83. PubMed ID: 2944246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA; Abujamra AC; Minanni SL; Mendonca BB; Nery M; Lerario AC; Pereira MA; Abelin N; Wajchenberg BL
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology and prognosis of peripheral precocious puberty in children].
    Yang XH; Chen RM; Zhang Y; Lin XQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Dec; 13(12):947-50. PubMed ID: 22172256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins.
    Rime JL; Zumsteg U; Blumberg A; Hadziselimovic F; Girard J; Zurbrügg RP
    Eur J Pediatr; 1988 Apr; 147(3):263-9. PubMed ID: 3134243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists.
    Lawson ML; Cohen N
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4536-40. PubMed ID: 10599714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue.
    Stanhope R; Pringle PJ; Brook CG
    Acta Paediatr Scand; 1988 Jul; 77(4):525-30. PubMed ID: 3293348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.
    Saggese G; Bertelloni S; Baroncelli GI; Pardi D; Cinquanta L
    J Endocrinol Invest; 1991 Mar; 14(3):231-6. PubMed ID: 1830057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.